Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD
Status:
Unknown status
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
To test the hypothesis that nebulized Pulmicort Respules could reduce post operation
pulmonary complication incidence in primary lung cancer patients with COPD. Compare
post-operation pulmonary complication incidence in two treatment arms among primary lung
cancer patients with COPD required single lobectomy from 3days before operation to 7 days
after operation.